| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.17e-05 | 188 | 113 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 1.83e-04 | 50 | 113 | 4 | GO:0003755 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 1.88e-04 | 20 | 113 | 3 | GO:0061665 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 1.89e-04 | 4 | 113 | 2 | GO:0030197 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 2.30e-04 | 53 | 113 | 4 | GO:0016859 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 3.87e-06 | 20 | 113 | 4 | GO:0006607 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 1.31e-05 | 9 | 113 | 3 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 1.87e-05 | 10 | 113 | 3 | GO:1903301 | |
| GeneOntologyBiologicalProcess | positive regulation of termination of DNA-templated transcription | 2.98e-05 | 2 | 113 | 2 | GO:0060566 | |
| GeneOntologyBiologicalProcess | positive regulation of termination of RNA polymerase II transcription | 2.98e-05 | 2 | 113 | 2 | GO:1904595 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 4.40e-05 | 13 | 113 | 3 | GO:0033131 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 5.46e-05 | 38 | 113 | 4 | GO:0000413 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 5.58e-05 | 14 | 113 | 3 | GO:1903299 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 5.71e-05 | 313 | 113 | 9 | GO:0098742 | |
| GeneOntologyBiologicalProcess | mitotic cytokinesis | 1.77e-04 | 95 | 113 | 5 | GO:0000281 | |
| GeneOntologyBiologicalProcess | condensed mesenchymal cell proliferation | 1.77e-04 | 4 | 113 | 2 | GO:0072137 | |
| GeneOntologyBiologicalProcess | regulation of termination of RNA polymerase II transcription | 1.77e-04 | 4 | 113 | 2 | GO:1904594 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 2.19e-04 | 54 | 113 | 4 | GO:0018208 | |
| GeneOntologyBiologicalProcess | specification of axis polarity | 2.94e-04 | 5 | 113 | 2 | GO:0065001 | |
| GeneOntologyBiologicalProcess | synaptic vesicle targeting | 2.94e-04 | 5 | 113 | 2 | GO:0016080 | |
| GeneOntologyBiologicalProcess | presynaptic active zone assembly | 2.94e-04 | 5 | 113 | 2 | GO:1904071 | |
| GeneOntologyBiologicalProcess | retina layer formation | 3.37e-04 | 25 | 113 | 3 | GO:0010842 | |
| GeneOntologyBiologicalProcess | regulation of nervous system process | 4.09e-04 | 175 | 113 | 6 | GO:0031644 | |
| GeneOntologyCellularComponent | Golgi lumen | 1.14e-08 | 109 | 118 | 9 | GO:0005796 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 9.62e-06 | 8 | 118 | 3 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 2.04e-05 | 10 | 118 | 3 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 6.10e-05 | 14 | 118 | 3 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 1.34e-04 | 18 | 118 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.86e-04 | 20 | 118 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 2.17e-04 | 21 | 118 | 3 | GO:0106068 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 1.11e-03 | 9 | 118 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | extracellular matrix | COL6A3 COL12A1 ZAN TNC MUC5B MUC17 VCAN FLRT3 PRG4 MUC6 HCFC1 | 1.23e-03 | 656 | 118 | 11 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL6A3 COL12A1 ZAN TNC MUC5B MUC17 VCAN FLRT3 PRG4 MUC6 HCFC1 | 1.26e-03 | 658 | 118 | 11 | GO:0030312 |
| GeneOntologyCellularComponent | bleb | 1.38e-03 | 10 | 118 | 2 | GO:0032059 | |
| GeneOntologyCellularComponent | perisynaptic extracellular matrix | 1.68e-03 | 11 | 118 | 2 | GO:0098966 | |
| Domain | SEA | 1.55e-08 | 14 | 115 | 5 | SM00200 | |
| Domain | FN3 | COL6A3 SDK2 COL12A1 DSCAM TNC CMYA5 DSCAML1 PTPRC FLRT3 HCFC1 | 2.16e-07 | 185 | 115 | 10 | SM00060 |
| Domain | SEA | 2.50e-07 | 23 | 115 | 5 | PS50024 | |
| Domain | SEA_dom | 2.50e-07 | 23 | 115 | 5 | IPR000082 | |
| Domain | FN3 | COL6A3 SDK2 COL12A1 DSCAM TNC CMYA5 DSCAML1 PTPRC FLRT3 HCFC1 | 4.25e-07 | 199 | 115 | 10 | PS50853 |
| Domain | Ran_BP1 | 6.50e-07 | 12 | 115 | 4 | PF00638 | |
| Domain | TIL | 6.50e-07 | 12 | 115 | 4 | PF01826 | |
| Domain | RANBD1 | 6.50e-07 | 12 | 115 | 4 | PS50196 | |
| Domain | C8 | 6.50e-07 | 12 | 115 | 4 | PF08742 | |
| Domain | FN3_dom | COL6A3 SDK2 COL12A1 DSCAM TNC CMYA5 DSCAML1 PTPRC FLRT3 HCFC1 | 6.66e-07 | 209 | 115 | 10 | IPR003961 |
| Domain | Unchr_dom_Cys-rich | 9.34e-07 | 13 | 115 | 4 | IPR014853 | |
| Domain | C8 | 9.34e-07 | 13 | 115 | 4 | SM00832 | |
| Domain | RanBD | 9.34e-07 | 13 | 115 | 4 | SM00160 | |
| Domain | Ran_bind_dom | 9.34e-07 | 13 | 115 | 4 | IPR000156 | |
| Domain | TIL_dom | 1.30e-06 | 14 | 115 | 4 | IPR002919 | |
| Domain | VWD | 2.34e-06 | 16 | 115 | 4 | SM00216 | |
| Domain | VWF_type-D | 2.34e-06 | 16 | 115 | 4 | IPR001846 | |
| Domain | VWFD | 2.34e-06 | 16 | 115 | 4 | PS51233 | |
| Domain | VWD | 2.34e-06 | 16 | 115 | 4 | PF00094 | |
| Domain | VWC_out | 4.92e-06 | 19 | 115 | 4 | SM00215 | |
| Domain | fn3 | 7.26e-06 | 162 | 115 | 8 | PF00041 | |
| Domain | SEA | 9.16e-06 | 22 | 115 | 4 | PF01390 | |
| Domain | Grip | 3.62e-05 | 11 | 115 | 3 | SM00755 | |
| Domain | GRIP | 3.62e-05 | 11 | 115 | 3 | PF01465 | |
| Domain | GRIP_dom | 4.80e-05 | 12 | 115 | 3 | IPR000237 | |
| Domain | GRIP | 4.80e-05 | 12 | 115 | 3 | PS50913 | |
| Domain | EGF_3 | 1.04e-04 | 235 | 115 | 8 | PS50026 | |
| Domain | EGF | 1.04e-04 | 235 | 115 | 8 | SM00181 | |
| Domain | Ig-like_fold | COL6A3 SDK2 COL12A1 DSCAM TNC LRRC4C CMYA5 DSCAML1 IGSF10 PTPRC IGHG4 VCAN FLRT3 HCFC1 | 1.12e-04 | 706 | 115 | 14 | IPR013783 |
| Domain | VWF_dom | 1.27e-04 | 42 | 115 | 4 | IPR001007 | |
| Domain | EGF-like_dom | 1.55e-04 | 249 | 115 | 8 | IPR000742 | |
| Domain | EGF_1 | 1.82e-04 | 255 | 115 | 8 | PS00022 | |
| Domain | EGF-like_CS | 2.13e-04 | 261 | 115 | 8 | IPR013032 | |
| Domain | - | COL6A3 SDK2 COL12A1 DSCAM TNC LRRC4C CMYA5 DSCAML1 IGSF10 PTPRC VCAN FLRT3 HCFC1 | 2.22e-04 | 663 | 115 | 13 | 2.60.40.10 |
| Domain | Cortactin-binding_p2_N | 2.24e-04 | 4 | 115 | 2 | IPR019131 | |
| Domain | CortBP2 | 2.24e-04 | 4 | 115 | 2 | PF09727 | |
| Domain | EGF_2 | 2.36e-04 | 265 | 115 | 8 | PS01186 | |
| Domain | CT | 3.22e-04 | 22 | 115 | 3 | SM00041 | |
| Domain | SAPAP | 3.71e-04 | 5 | 115 | 2 | IPR005026 | |
| Domain | GKAP | 3.71e-04 | 5 | 115 | 2 | PF03359 | |
| Domain | Lipid-bd_serum_glycop_CS | 3.71e-04 | 5 | 115 | 2 | IPR017954 | |
| Domain | Cys_knot_C | 4.74e-04 | 25 | 115 | 3 | IPR006207 | |
| Domain | CTCK_2 | 4.74e-04 | 25 | 115 | 3 | PS01225 | |
| Domain | GCC2_Rab_bind | 7.74e-04 | 7 | 115 | 2 | IPR032023 | |
| Domain | Rab_bind | 7.74e-04 | 7 | 115 | 2 | PF16704 | |
| Domain | GPS | 1.18e-03 | 34 | 115 | 3 | SM00303 | |
| Domain | IGv | 1.18e-03 | 75 | 115 | 4 | SM00406 | |
| Domain | PH_dom-like | 1.28e-03 | 426 | 115 | 9 | IPR011993 | |
| Domain | GPS | 1.29e-03 | 35 | 115 | 3 | PF01825 | |
| Domain | BPI1 | 1.32e-03 | 9 | 115 | 2 | SM00328 | |
| Domain | LBP_BPI_CETP | 1.32e-03 | 9 | 115 | 2 | PS00400 | |
| Domain | BPI2 | 1.32e-03 | 9 | 115 | 2 | SM00329 | |
| Domain | GPS | 1.40e-03 | 36 | 115 | 3 | PS50221 | |
| Domain | GPS | 1.52e-03 | 37 | 115 | 3 | IPR000203 | |
| Domain | LBP_BPI_CETP_C | 1.64e-03 | 10 | 115 | 2 | PF02886 | |
| Domain | - | 1.64e-03 | 10 | 115 | 2 | 1.10.220.60 | |
| Domain | VWC | 1.64e-03 | 38 | 115 | 3 | SM00214 | |
| Domain | VWFC_2 | 1.64e-03 | 38 | 115 | 3 | PS50184 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 1.90e-03 | 40 | 115 | 3 | PS00649 | |
| Domain | GPCR_2_extracellular_dom | 1.90e-03 | 40 | 115 | 3 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 1.90e-03 | 40 | 115 | 3 | PS50227 | |
| Domain | Znf_FYVE_PHD | 2.16e-03 | 147 | 115 | 5 | IPR011011 | |
| Domain | TPR_1 | 2.32e-03 | 90 | 115 | 4 | PF00515 | |
| Domain | TPR_1 | 2.32e-03 | 90 | 115 | 4 | IPR001440 | |
| Domain | ConA-like_dom | 2.36e-03 | 219 | 115 | 6 | IPR013320 | |
| Domain | Lipid-bd_serum_glycop_C | 2.38e-03 | 12 | 115 | 2 | IPR001124 | |
| Domain | HTH_Tnp_Tc5 | 2.80e-03 | 13 | 115 | 2 | PF03221 | |
| Domain | LBP_BPI_CETP | 2.80e-03 | 13 | 115 | 2 | PF01273 | |
| Domain | BPI/LBP/Plunc | 2.80e-03 | 13 | 115 | 2 | IPR032942 | |
| Domain | Bactericidal_perm-incr_a/b_dom | 2.80e-03 | 13 | 115 | 2 | IPR017943 | |
| Domain | Lipid-bd_serum_glycop_N | 2.80e-03 | 13 | 115 | 2 | IPR017942 | |
| Domain | - | 2.82e-03 | 95 | 115 | 4 | 2.60.120.200 | |
| Domain | - | 2.90e-03 | 391 | 115 | 8 | 2.30.29.30 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 3.61e-03 | 50 | 115 | 3 | PS00650 | |
| Domain | 7tm_2 | 3.61e-03 | 50 | 115 | 3 | PF00002 | |
| Domain | - | 3.74e-03 | 15 | 115 | 2 | 3.30.70.960 | |
| Domain | CTCK_1 | 5.39e-03 | 18 | 115 | 2 | PS01185 | |
| Domain | Cyclophilin-type_PPIase_CS | 6.00e-03 | 19 | 115 | 2 | IPR020892 | |
| Domain | GPCR_2_secretin-like | 6.03e-03 | 60 | 115 | 3 | IPR000832 | |
| Domain | GPCR_2-like | 6.03e-03 | 60 | 115 | 3 | IPR017981 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 2.28e-10 | 16 | 81 | 6 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 3.51e-10 | 17 | 81 | 6 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.51e-09 | 21 | 81 | 6 | MM15706 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.78e-09 | 23 | 81 | 6 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 6.26e-09 | 26 | 81 | 6 | M27483 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.17e-06 | 60 | 81 | 6 | MM15636 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.42e-06 | 62 | 81 | 6 | M546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.46e-06 | 68 | 81 | 6 | M27303 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.77e-05 | 143 | 81 | 7 | M27275 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.77e-05 | 109 | 81 | 6 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 4.18e-05 | 111 | 81 | 6 | M27416 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 1.40e-04 | 18 | 81 | 3 | MM1549 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 1.52e-04 | 140 | 81 | 6 | M27484 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 5.78e-04 | 250 | 81 | 7 | M27554 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 8.04e-04 | 32 | 81 | 3 | MM15326 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 1.33e-13 | 18 | 118 | 7 | 18834073 | |
| Pubmed | TET2 PHF12 ZMYND8 RBM26 RNF40 BCOR ANLN MDC1 RPRD2 MGA SAP130 HCFC1 | 1.42e-10 | 268 | 118 | 12 | 33640491 | |
| Pubmed | TET2 SDK2 SETX CDC42BPA PHF12 RNF40 POGZ ADGRV1 BCOR MAST4 MDC1 AKAP11 RPRD2 FLRT3 ADGRL2 | 3.81e-10 | 529 | 118 | 15 | 14621295 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 4.16e-10 | 123 | 118 | 9 | 26912792 | |
| Pubmed | 1.88e-09 | 6 | 118 | 4 | 19110483 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.91e-09 | 146 | 118 | 9 | 23892456 | |
| Pubmed | TET2 RANBP2 RGPD8 PHF12 ZMYND8 RGPD1 RNF40 POGZ BCOR GOLGA5 MGA ARHGAP21 WDR62 | 2.02e-09 | 418 | 118 | 13 | 34709266 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | VAPB RANBP2 ILF2 SETX MAFK PHF12 ZMYND8 RNF40 POGZ BCOR RFX7 MDC1 SAP30BP RPRD2 NKTR MGA NOP2 SAP130 HCFC1 LRIF1 SON | 2.51e-09 | 1294 | 118 | 21 | 30804502 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RANBP2 ILF2 SETX ZMYND8 RBM26 ZNF207 POGZ BCOR ANLN MDC1 SAP30BP SGO2 RPRD2 MGA NOP2 SAP130 HCFC1 SON | 3.94e-09 | 954 | 118 | 18 | 36373674 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FILIP1 RANBP2 PHF12 SPTBN1 ZMYND8 POGZ BCOR RFX7 PTPRC ANLN MDC1 PACS2 NOP2 PRG4 WDR62 SON | 8.78e-09 | 774 | 118 | 16 | 15302935 |
| Pubmed | ILF2 MUC19 RNF40 POGZ BCOR ANLN RPRD2 MGA SAP130 HCFC1 LRIF1 | 2.43e-08 | 339 | 118 | 11 | 30415952 | |
| Pubmed | VAPB RGPD8 RBM26 RNF40 WNK1 C2CD2L SLC6A8 ANLN MDC1 PIP4K2B RPRD2 GOLGA5 MGA HCFC1 WDR62 | 3.03e-08 | 733 | 118 | 15 | 34672954 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 3.25e-08 | 271 | 118 | 10 | 32433965 | |
| Pubmed | TET2 RANBP2 ILF2 SETX MAFK PHF12 ZMYND8 RBM26 ZNF207 POGZ BCOR ANLN GMEB1 NOP2 SAP130 HCFC1 LRIF1 ZNF292 | 3.62e-08 | 1103 | 118 | 18 | 34189442 | |
| Pubmed | 3.81e-08 | 3 | 118 | 3 | 10512748 | ||
| Pubmed | TET2 ILF2 CDC42BPA PHF12 SPTBN1 ZMYND8 RGPD1 POGZ MLLT10 BCOR RFX7 MDC1 GMEB1 RPRD2 MGA NOP2 SAP130 HCFC1 LRIF1 FILIP1L | 7.23e-08 | 1429 | 118 | 20 | 35140242 | |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 8.79e-08 | 13 | 118 | 4 | 31427429 | |
| Pubmed | 1.23e-07 | 14 | 118 | 4 | 16452088 | ||
| Pubmed | 1.52e-07 | 4 | 118 | 3 | 9480752 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SETX PHF12 POGZ BCOR ANLN MDC1 SGO2 MGA NOP2 PRDM15 HCFC1 LRIF1 ZNF292 | 1.63e-07 | 608 | 118 | 13 | 36089195 |
| Pubmed | Interaction network of human early embryonic transcription factors. | 3.58e-07 | 351 | 118 | 10 | 38297188 | |
| Pubmed | ANK3 RBM26 POGZ BCOR ANLN MDC1 SAP30BP RPRD2 MGA SAP130 HCFC1 RGPD5 | 3.98e-07 | 549 | 118 | 12 | 38280479 | |
| Pubmed | 4.45e-07 | 453 | 118 | 11 | 29656893 | ||
| Pubmed | 5.06e-07 | 86 | 118 | 6 | 37253089 | ||
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 7.79e-07 | 148 | 118 | 7 | 32538781 | |
| Pubmed | DLGAP1 RANBP2 SETX CDC42BPA ANK3 SPTBN1 POGZ WNK1 KIAA1549L NKTR MGA | 8.85e-07 | 486 | 118 | 11 | 20936779 | |
| Pubmed | 9.44e-07 | 52 | 118 | 5 | 26633812 | ||
| Pubmed | 9.73e-07 | 222 | 118 | 8 | 37071664 | ||
| Pubmed | 1.16e-06 | 99 | 118 | 6 | 27746211 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.31e-06 | 231 | 118 | 8 | 16452087 | |
| Pubmed | 1.32e-06 | 7 | 118 | 3 | 21205196 | ||
| Pubmed | 1.32e-06 | 7 | 118 | 3 | 18949001 | ||
| Pubmed | 1.32e-06 | 7 | 118 | 3 | 25187515 | ||
| Pubmed | 1.32e-06 | 7 | 118 | 3 | 9037092 | ||
| Pubmed | 1.32e-06 | 7 | 118 | 3 | 8603673 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.32e-06 | 7 | 118 | 3 | 15710750 | |
| Pubmed | 1.32e-06 | 7 | 118 | 3 | 26632511 | ||
| Pubmed | 1.32e-06 | 7 | 118 | 3 | 24403063 | ||
| Pubmed | 1.32e-06 | 7 | 118 | 3 | 23818861 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 1.32e-06 | 7 | 118 | 3 | 11353387 | |
| Pubmed | 1.32e-06 | 7 | 118 | 3 | 30944974 | ||
| Pubmed | 1.32e-06 | 7 | 118 | 3 | 38838144 | ||
| Pubmed | 1.32e-06 | 7 | 118 | 3 | 23536549 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 1.32e-06 | 7 | 118 | 3 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 1.32e-06 | 7 | 118 | 3 | 17372272 | |
| Pubmed | 1.32e-06 | 7 | 118 | 3 | 38657106 | ||
| Pubmed | 1.32e-06 | 7 | 118 | 3 | 12191015 | ||
| Pubmed | 1.32e-06 | 7 | 118 | 3 | 22821000 | ||
| Pubmed | 1.32e-06 | 7 | 118 | 3 | 20682751 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TET2 SETX CDC42BPA SPTBN1 FRYL RFX7 WNK1 MAST4 ANLN AKAP11 FGD6 ARHGAP21 WDR62 CCSER1 | 1.41e-06 | 861 | 118 | 14 | 36931259 |
| Pubmed | 1.44e-06 | 234 | 118 | 8 | 36243803 | ||
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 2.11e-06 | 8 | 118 | 3 | 22262462 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 2.11e-06 | 8 | 118 | 3 | 21670213 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 2.11e-06 | 8 | 118 | 3 | 28745977 | |
| Pubmed | 2.11e-06 | 8 | 118 | 3 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 2.11e-06 | 8 | 118 | 3 | 21310149 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 2.23e-06 | 430 | 118 | 10 | 35044719 | |
| Pubmed | RANBP2 ILF2 MAFK SPTBN1 POGZ IGHG4 MDC1 SGO2 NOP2 HCFC1 LRIF1 SON | 2.38e-06 | 652 | 118 | 12 | 31180492 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 3.15e-06 | 9 | 118 | 3 | 18394993 | |
| Pubmed | 3.15e-06 | 9 | 118 | 3 | 11553612 | ||
| Pubmed | 3.15e-06 | 9 | 118 | 3 | 10601307 | ||
| Pubmed | 3.15e-06 | 9 | 118 | 3 | 9733766 | ||
| Pubmed | 3.15e-06 | 9 | 118 | 3 | 28100513 | ||
| Pubmed | 3.15e-06 | 9 | 118 | 3 | 28877029 | ||
| Pubmed | 3.15e-06 | 9 | 118 | 3 | 17887960 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | VAPB RANBP2 ZMYND8 RBM26 BCOR WNK1 SAP30BP RPRD2 GOLGA5 NOP2 HCFC1 ARHGAP21 WDR62 SON | 3.62e-06 | 934 | 118 | 14 | 33916271 |
| Pubmed | AHI1 ILF2 SETX ANK3 SPTBN1 CD55 FRYL BCOR WNK1 PTPRC ANLN VCAN POLK MGA ARHGAP21 | 4.18e-06 | 1084 | 118 | 15 | 11544199 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 4.38e-06 | 363 | 118 | 9 | 14691545 | |
| Pubmed | Identification of host proteins required for HIV infection through a functional genomic screen. | 4.40e-06 | 272 | 118 | 8 | 18187620 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 4.49e-06 | 10 | 118 | 3 | 8857542 | |
| Pubmed | 4.49e-06 | 10 | 118 | 3 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 4.49e-06 | 10 | 118 | 3 | 16332688 | |
| Pubmed | 4.49e-06 | 10 | 118 | 3 | 21859863 | ||
| Pubmed | DLGAP2 DLGAP1 RANBP2 ILF2 RGPD8 ANK3 DSCAM SPTBN1 RGPD1 TPPP BCOR MGA NOP2 ARHGAP21 | 5.13e-06 | 963 | 118 | 14 | 28671696 | |
| Pubmed | 5.21e-06 | 197 | 118 | 7 | 36604605 | ||
| Pubmed | 5.52e-06 | 74 | 118 | 5 | 29795351 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 5.58e-06 | 281 | 118 | 8 | 28706196 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 5.88e-06 | 283 | 118 | 8 | 30585729 | |
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 6.16e-06 | 11 | 118 | 3 | 35771867 | |
| Pubmed | Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. | 6.16e-06 | 11 | 118 | 3 | 20351715 | |
| Pubmed | 6.16e-06 | 11 | 118 | 3 | 17069463 | ||
| Pubmed | 6.16e-06 | 11 | 118 | 3 | 34110283 | ||
| Pubmed | 7.92e-06 | 210 | 118 | 7 | 16565220 | ||
| Pubmed | COL6A3 RANBP2 COL12A1 CDC42BPA SPTBN1 CMYA5 WNK1 MGA ARHGAP21 SON | 7.98e-06 | 497 | 118 | 10 | 23414517 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | BDP1 DCHS2 ANK3 SPTBN1 ZMYND8 RBM26 SAP30BP HCFC1 ARHGAP21 ZNF292 | 7.98e-06 | 497 | 118 | 10 | 36774506 |
| Pubmed | 8.86e-06 | 503 | 118 | 10 | 16964243 | ||
| Pubmed | 9.36e-06 | 399 | 118 | 9 | 35987950 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 17495597 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 16493581 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 12958310 | ||
| Pubmed | Elevation of plasma phospholipid transfer protein in transgenic mice increases VLDL secretion. | 1.14e-05 | 2 | 118 | 2 | 12401886 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 24805859 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 17074766 | ||
| Pubmed | BCOR-CCNB3 fusion-positive clear cell sarcoma of the kidney. | 1.14e-05 | 2 | 118 | 2 | 31876361 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 30064235 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 21645617 | ||
| Pubmed | Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B. | 1.14e-05 | 2 | 118 | 2 | 10973822 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 15003449 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 25451118 | ||
| Pubmed | Complete cDNA encoding human phospholipid transfer protein from human endothelial cells. | 1.14e-05 | 2 | 118 | 2 | 8132678 | |
| Interaction | NUP43 interactions | RANBP2 SETX RGPD8 DSCAM PHF12 ZMYND8 RBM26 MUC19 CCDC168 POGZ BCOR MDC1 NKTR MGA HCFC1 SON ZNF292 RGPD5 | 1.83e-08 | 625 | 116 | 18 | int:NUP43 |
| Interaction | H2BC21 interactions | PHF12 PCLO ZMYND8 RNF40 POGZ STING1 MLLT10 BCOR C2CD2L KIAA1549L MDC1 SGO2 AKAP11 RPRD2 NOP2 HCFC1 LRIF1 ZNF292 | 9.32e-08 | 696 | 116 | 18 | int:H2BC21 |
| Interaction | TAFA5 interactions | 3.00e-06 | 18 | 116 | 4 | int:TAFA5 | |
| Interaction | NPIPB6 interactions | 3.00e-06 | 18 | 116 | 4 | int:NPIPB6 | |
| Interaction | RGPD4 interactions | 7.04e-06 | 22 | 116 | 4 | int:RGPD4 | |
| Interaction | DLG2 interactions | 8.40e-06 | 83 | 116 | 6 | int:DLG2 | |
| Interaction | ASF1A interactions | 1.40e-05 | 249 | 116 | 9 | int:ASF1A | |
| Interaction | SMC5 interactions | RANBP2 ILF2 SETX ZMYND8 RBM26 ZNF207 POGZ BCOR ANLN MDC1 SAP30BP SGO2 RPRD2 MGA NOP2 SAP130 HCFC1 SON | 1.61e-05 | 1000 | 116 | 18 | int:SMC5 |
| Interaction | RGPD2 interactions | 1.65e-05 | 27 | 116 | 4 | int:RGPD2 | |
| Interaction | TERF2IP interactions | SETX ZMYND8 RNF40 POGZ BCOR ANLN MDC1 SAP30BP MGA SAP130 HCFC1 LRIF1 ZNF292 | 1.78e-05 | 552 | 116 | 13 | int:TERF2IP |
| Interaction | YWHAB interactions | VAPB TET2 DLGAP1 CDC42BPA SPTBN1 FRYL RFX7 WNK1 MAST4 ANLN PACS2 AKAP11 FGD6 SAP130 ARHGAP21 WDR62 SON CCSER1 | 1.93e-05 | 1014 | 116 | 18 | int:YWHAB |
| Interaction | DSCAML1 interactions | 2.17e-05 | 10 | 116 | 3 | int:DSCAML1 | |
| Interaction | CIT interactions | DLGAP1 RANBP2 ILF2 SETX DSCAM PCLO SPTBN1 ZMYND8 CD55 RNF40 HEATR5A POGZ ADGRV1 CMYA5 ANLN MDC1 NKTR CCDC180 NOP2 HCFC1 SON CCSER1 | 2.41e-05 | 1450 | 116 | 22 | int:CIT |
| Interaction | YWHAG interactions | VAPB TET2 DLGAP1 CDC42BPA SPTBN1 FRYL STING1 RFX7 WNK1 C2CD2L MAST4 ANLN PACS2 AKAP11 NKTR FGD6 ARHGAP21 WDR62 SON CCSER1 | 2.77e-05 | 1248 | 116 | 20 | int:YWHAG |
| Interaction | PHF21A interactions | RANBP2 PHF12 ZMYND8 RNF40 STING1 BCOR GOLGA5 MGA ARHGAP21 WDR62 | 2.96e-05 | 343 | 116 | 10 | int:PHF21A |
| Interaction | SFN interactions | TET2 CDC42BPA SPTBN1 FRYL WNK1 MAST4 ANLN PACS2 AKAP11 FGD6 SAP130 ARHGAP21 WDR62 CCSER1 | 4.43e-05 | 692 | 116 | 14 | int:SFN |
| Interaction | ZFPL1 interactions | VAPB CDC42BPA ANK3 SPTBN1 LAMP2 STING1 C2CD2L SLC6A8 GOLGA5 ADGRL2 ARHGAP21 | 5.60e-05 | 448 | 116 | 11 | int:ZFPL1 |
| Interaction | USP7 interactions | TET2 DLGAP1 SDK2 CDC42BPA ZAN RGPD8 SPTBN1 ZMYND8 ZNF207 STING1 TEX15 BCOR SLC6A8 KIAA1549L ANLN MDC1 SAP30BP PIP4K2B NOP2 SAP130 | 5.66e-05 | 1313 | 116 | 20 | int:USP7 |
| Interaction | YWHAH interactions | VAPB TET2 DLGAP1 SETX CDC42BPA SPTBN1 FRYL RFX7 WNK1 MAST4 ANLN PACS2 AKAP11 NKTR FGD6 ARHGAP21 WDR62 CCSER1 | 5.76e-05 | 1102 | 116 | 18 | int:YWHAH |
| Interaction | IER2 interactions | 5.94e-05 | 37 | 116 | 4 | int:IER2 | |
| Interaction | EGR2 interactions | 6.01e-05 | 171 | 116 | 7 | int:EGR2 | |
| Interaction | CEBPA interactions | TET2 RANBP2 ILF2 SETX MAFK PHF12 SPTBN1 ZMYND8 RBM26 ZNF207 POGZ BCOR ANLN GMEB1 NOP2 SAP130 HCFC1 LRIF1 ZNF292 | 8.69e-05 | 1245 | 116 | 19 | int:CEBPA |
| Interaction | YWHAE interactions | VAPB TET2 DLGAP1 AHI1 ILF2 CDC42BPA FRYL STING1 WNK1 MAST4 ANLN PACS2 AKAP11 MGA FGD6 SAP130 ARHGAP21 WDR62 CCSER1 | 9.75e-05 | 1256 | 116 | 19 | int:YWHAE |
| Interaction | FHL2 interactions | 9.82e-05 | 396 | 116 | 10 | int:FHL2 | |
| Interaction | TRAF3IP3 interactions | 1.24e-04 | 84 | 116 | 5 | int:TRAF3IP3 | |
| Interaction | H3C3 interactions | 1.36e-04 | 495 | 116 | 11 | int:H3C3 | |
| Interaction | KLF5 interactions | 1.37e-04 | 195 | 116 | 7 | int:KLF5 | |
| Interaction | GJA1 interactions | VAPB SDK2 CDC42BPA ANK3 SPTBN1 LAMP2 HEATR5A SLC6A8 FLRT3 GOLGA5 ADGRL2 ARHGAP21 | 1.37e-04 | 583 | 116 | 12 | int:GJA1 |
| Interaction | ARF6 interactions | VAPB CDC42BPA ANK3 SPTBN1 LAMP2 STING1 SLC6A8 ANLN FLRT3 GOLGA5 ADGRL2 ARHGAP21 | 1.39e-04 | 584 | 116 | 12 | int:ARF6 |
| Interaction | RGPD3 interactions | 1.54e-04 | 47 | 116 | 4 | int:RGPD3 | |
| Interaction | NUP50 interactions | 1.59e-04 | 341 | 116 | 9 | int:NUP50 | |
| Interaction | NEMP1 interactions | 1.64e-04 | 89 | 116 | 5 | int:NEMP1 | |
| Interaction | MAGI2 interactions | 1.67e-04 | 48 | 116 | 4 | int:MAGI2 | |
| Interaction | RGPD1 interactions | 1.81e-04 | 49 | 116 | 4 | int:RGPD1 | |
| Interaction | CPNE4 interactions | 1.81e-04 | 49 | 116 | 4 | int:CPNE4 | |
| Interaction | YWHAZ interactions | VAPB TET2 BDP1 DLGAP1 CDC42BPA SPTBN1 RBM26 FRYL BCOR WNK1 MAST4 ANLN MDC1 PACS2 AKAP11 FGD6 ARHGAP21 WDR62 CCSER1 | 1.84e-04 | 1319 | 116 | 19 | int:YWHAZ |
| Interaction | SPTBN4 interactions | 1.96e-04 | 50 | 116 | 4 | int:SPTBN4 | |
| Interaction | NFIC interactions | 2.16e-04 | 210 | 116 | 7 | int:NFIC | |
| Interaction | AGAP2 interactions | 2.16e-04 | 210 | 116 | 7 | int:AGAP2 | |
| Interaction | RGPD5 interactions | 2.33e-04 | 96 | 116 | 5 | int:RGPD5 | |
| Interaction | ADAR interactions | 2.52e-04 | 286 | 116 | 8 | int:ADAR | |
| Interaction | POLR3H interactions | 2.69e-04 | 99 | 116 | 5 | int:POLR3H | |
| Interaction | SIRT6 interactions | RANBP2 FAT4 RGPD8 PSMG3 RNF40 BCOR MDC1 SGO2 RPRD2 NKTR NOP2 RGPD5 | 2.71e-04 | 628 | 116 | 12 | int:SIRT6 |
| Interaction | KLF15 interactions | 2.77e-04 | 290 | 116 | 8 | int:KLF15 | |
| Interaction | DHX8 interactions | 2.90e-04 | 292 | 116 | 8 | int:DHX8 | |
| Cytoband | 5q13 | 2.46e-05 | 22 | 118 | 3 | 5q13 | |
| Cytoband | 7q22 | 1.31e-04 | 38 | 118 | 3 | 7q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p22 | 4.12e-04 | 134 | 118 | 4 | chr7p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q31 | 9.77e-04 | 75 | 118 | 3 | chr1q31 | |
| GeneFamily | CD molecules|Mucins | 3.63e-19 | 21 | 77 | 10 | 648 | |
| GeneFamily | Fibronectin type III domain containing | 3.96e-07 | 160 | 77 | 8 | 555 | |
| GeneFamily | Cyclophilin peptidylprolyl isomerases | 6.85e-05 | 19 | 77 | 3 | 909 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.20e-04 | 161 | 77 | 5 | 593 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.47e-03 | 115 | 77 | 4 | 769 | |
| GeneFamily | BPI fold containing | 2.07e-03 | 16 | 77 | 2 | 456 | |
| GeneFamily | Cadherin related | 2.34e-03 | 17 | 77 | 2 | 24 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 2.34e-03 | 17 | 77 | 2 | 1197 | |
| GeneFamily | PHD finger proteins | 6.69e-03 | 90 | 77 | 3 | 88 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 6.75e-03 | 29 | 77 | 2 | 396 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 7.45e-03 | 181 | 77 | 4 | 694 | |
| Coexpression | NABA_ECM_AFFILIATED | 7.45e-08 | 170 | 117 | 9 | M5880 | |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | FILIP1 DLGAP2 DCHS2 AHI1 RGPD8 MEIOB HEATR5A POGZ LRRC4C ADGRV1 SLC6A8 MUC17 TDRD6 ADGRL2 CCDC33 CCSER1 | 1.74e-06 | 873 | 117 | 16 | M16009 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | BDP1 ANK3 DSCAM PCLO MFSD6 ZMYND8 RBM26 MUC19 NLGN1 RFX7 DSCAML1 ZNF385D MAST4 KIAA1549L VCAN PIP4K2B TMEM255A CCSER1 | 2.00e-06 | 1106 | 117 | 18 | M39071 |
| Coexpression | NABA_ECM_AFFILIATED | 7.21e-06 | 158 | 117 | 7 | MM17063 | |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 1.27e-05 | 240 | 117 | 8 | M39236 | |
| Coexpression | NABA_MATRISOME | COL6A3 COL12A1 TNC MUC19 MUC16 MUC5B MUC13 IGSF10 MUC17 VCAN MUC22 MUC3A PRG4 MUC6 HCFC1 EMCN | 1.33e-05 | 1026 | 117 | 16 | M5889 |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 1.51e-05 | 177 | 117 | 7 | M39245 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP | 1.76e-05 | 121 | 117 | 6 | M12828 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP | 2.88e-05 | 132 | 117 | 6 | MM465 | |
| Coexpression | WHITFIELD_CELL_CYCLE_G2_M | 3.10e-05 | 198 | 117 | 7 | M2077 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 3.18e-05 | 81 | 117 | 5 | M39253 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM | 5.55e-05 | 217 | 117 | 7 | M16407 | |
| Coexpression | THUM_SYSTOLIC_HEART_FAILURE_DN | 7.37e-05 | 227 | 117 | 7 | M18441 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM | 7.58e-05 | 228 | 117 | 7 | MM1014 | |
| Coexpression | MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP | 9.35e-05 | 20 | 117 | 3 | M5409 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | COL12A1 MAFK TNC SPTBN1 ZMYND8 CD55 POGZ PRDM10 MAST4 ANLN MDC1 ARHGAP21 RGPD5 | 1.02e-04 | 843 | 117 | 13 | M2356 |
| Coexpression | GSE14699_NAIVE_VS_ACT_CD8_TCELL_DN | 1.38e-04 | 175 | 117 | 6 | M2940 | |
| Coexpression | ANDERSEN_CHOLANGIOCARCINOMA_CLASS2 | 1.38e-04 | 175 | 117 | 6 | M246 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | 1.50e-04 | 435 | 117 | 9 | MM1221 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.61e-04 | 180 | 117 | 6 | M8239 | |
| Coexpression | NABA_MATRISOME | COL6A3 COL12A1 TNC MUC19 MUC16 MUC5B MUC13 IGSF10 MUC17 VCAN PRG4 MUC6 HCFC1 EMCN | 1.64e-04 | 1008 | 117 | 14 | MM17056 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | BDP1 AHI1 SETX CDC42BPA RBM26 CD55 ANLN AKAP11 NKTR POLK SON | 1.75e-04 | 656 | 117 | 11 | M18979 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | COL6A3 FAT4 COL12A1 CD55 MUC16 LRRC4C TEX15 LHX9 IGSF10 VCAN ADGRL2 TMEM255A | 6.09e-07 | 357 | 116 | 12 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 4.83e-06 | 122 | 116 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | SPTBN1 RBM26 MEIOB CD55 ZNF207 TEX15 LHX9 MAST4 CCNB3 TAF4B MGA | 9.09e-06 | 387 | 116 | 11 | gudmap_developingGonad_e18.5_ovary_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | COL6A3 FAT4 COL12A1 CD55 MUC16 LRRC4C TEX15 LHX9 VCAN ADGRL2 TMEM255A | 9.31e-06 | 388 | 116 | 11 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | COL6A3 FAT4 COL12A1 CD55 MUC16 LAMP2 LRRC4C TEX15 WNK1 LHX9 IGSF10 VCAN AKAP11 ADGRL2 TMEM255A | 1.24e-05 | 740 | 116 | 15 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.53e-05 | 265 | 116 | 9 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 1.57e-05 | 146 | 116 | 7 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_200 | 2.04e-05 | 152 | 116 | 7 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | SPTBN1 RBM26 MEIOB CD55 ZNF207 TEX15 WNK1 LHX9 MAST4 CCNB3 GMEB1 NKTR TAF4B MGA TMEM255A | 2.22e-05 | 778 | 116 | 15 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_500 | 6.64e-05 | 40 | 116 | 4 | gudmap_developingGonad_e18.5_ovary_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | SPTBN1 RBM26 CD55 ZNF207 TEX15 WNK1 LHX9 LRR1 MAST4 GMEB1 NKTR TAF4B MGA CCSER1 | 7.98e-05 | 770 | 116 | 14 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#2_top-relative-expression-ranked_200 | 8.06e-05 | 42 | 116 | 4 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k2_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | SPTBN1 RBM26 MEIOB TPPP ZNF207 TEX15 LHX9 LRR1 MAST4 CCNB3 GMEB1 NKTR TAF4B MGA | 8.67e-05 | 776 | 116 | 14 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | TET2 COL6A3 TNC CD55 MUC16 LRRC4C LHX9 IGSF10 ANLN VCAN MDC1 SGO2 PLTP TMEM255A | 8.78e-05 | 777 | 116 | 14 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 9.07e-05 | 413 | 116 | 10 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_100 | 1.03e-04 | 85 | 116 | 5 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | COL6A3 FAT4 COL12A1 CD55 MUC16 LAMP2 STING1 LRRC4C TEX15 LHX9 IGSF10 VCAN ADGRL2 TMEM255A | 1.15e-04 | 797 | 116 | 14 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_200 | 1.36e-04 | 143 | 116 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.57e-04 | 281 | 116 | 8 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 1.58e-04 | 147 | 116 | 6 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_200 | 1.64e-04 | 148 | 116 | 6 | gudmap_developingGonad_e14.5_ ovary_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 1.66e-04 | 361 | 116 | 9 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 1.96e-04 | 153 | 116 | 6 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_500 | 2.07e-04 | 372 | 116 | 9 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.17e-04 | 54 | 116 | 4 | gudmap_developingGonad_P2_ovary_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | 2.52e-04 | 382 | 116 | 9 | gudmap_developingGonad_e14.5_ ovary_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 2.54e-04 | 469 | 116 | 10 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.05e-04 | 59 | 116 | 4 | gudmap_developingGonad_e16.5_testes_1000_k2 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.06e-04 | 310 | 116 | 8 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.13e-04 | 311 | 116 | 8 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | SETX PCLO SPTBN1 MFSD6 ZMYND8 RNF40 HEATR5A ADGRV1 MLLT10 KIAA1549L ANLN MDC1 HCFC1 PLTP WDR62 | 3.37e-04 | 994 | 116 | 15 | Facebase_RNAseq_e8.5_Floor Plate_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.63e-04 | 241 | 116 | 7 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 3.80e-04 | 404 | 116 | 9 | gudmap_developingGonad_e18.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_500 | 3.93e-04 | 406 | 116 | 9 | gudmap_developingGonad_e12.5_testes_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 3.93e-04 | 406 | 116 | 9 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_500 | 4.30e-04 | 411 | 116 | 9 | gudmap_developingGonad_e14.5_ testes_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_200 | 4.71e-04 | 28 | 116 | 3 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k1_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500 | 5.29e-04 | 423 | 116 | 9 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.33e-04 | 337 | 116 | 8 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | FAT4 AHI1 COL12A1 ANK3 CD55 ADGRV1 BCOR ANLN SGO2 RPRD2 ADGRL2 FGD6 FILIP1L | 5.38e-04 | 819 | 116 | 13 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 5.58e-04 | 259 | 116 | 7 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.58e-04 | 259 | 116 | 7 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_500 | 6.68e-04 | 127 | 116 | 5 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k2_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 6.81e-04 | 532 | 116 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | 7.42e-04 | 130 | 116 | 5 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K1 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_200 | 7.69e-04 | 33 | 116 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k3_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_100 | 8.01e-04 | 76 | 116 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_200 | 8.01e-04 | 76 | 116 | 4 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k3_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_100 | 8.83e-04 | 78 | 116 | 4 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000 | BDP1 COL6A3 SETX TNC PCLO ADGRV1 KIAA1549L MDC1 SGO2 FGD6 MUC6 LRIF1 FILIP1L CCDC33 | 9.10e-04 | 979 | 116 | 14 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.59e-04 | 284 | 116 | 7 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_100 | 9.71e-04 | 80 | 116 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 9.73e-04 | 207 | 116 | 6 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | TET2 COL6A3 TNC CD55 MUC16 LHX9 IGSF10 ANLN VCAN ADGRL2 PLTP TMEM255A | 1.01e-03 | 768 | 116 | 12 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.05e-03 | 210 | 116 | 6 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_100 | 1.07e-03 | 82 | 116 | 4 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#1_top-relative-expression-ranked_200 | 1.08e-03 | 37 | 116 | 3 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k1_200 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-09 | 184 | 117 | 9 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.71e-09 | 197 | 117 | 9 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.09e-09 | 200 | 117 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 3.09e-09 | 200 | 117 | 9 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.64e-08 | 180 | 117 | 8 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-08 | 184 | 117 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-08 | 184 | 117 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-08 | 184 | 117 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.91e-08 | 195 | 117 | 8 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.31e-08 | 197 | 117 | 8 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.31e-08 | 197 | 117 | 8 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.52e-08 | 198 | 117 | 8 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.52e-08 | 198 | 117 | 8 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.97e-08 | 200 | 117 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-07 | 160 | 117 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-07 | 160 | 117 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.81e-07 | 179 | 117 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 5.58e-07 | 183 | 117 | 7 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.01e-07 | 185 | 117 | 7 | ef3c1fd52d21d96f81fb0e5097b24be0ce16e222 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.01e-07 | 185 | 117 | 7 | c357fa098b561da16c9fa82b0c3563b5cd3fa875 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.46e-07 | 187 | 117 | 7 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.19e-07 | 190 | 117 | 7 | 23f2ac4da431211084bb6ab0494c2e0b69547cb6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.19e-07 | 190 | 117 | 7 | 3c337374d89e69cc0a78e65a4a7e21db7b050fcd | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 7.19e-07 | 190 | 117 | 7 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 7.44e-07 | 191 | 117 | 7 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 7.98e-07 | 193 | 117 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.98e-07 | 193 | 117 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.26e-07 | 194 | 117 | 7 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.55e-07 | 195 | 117 | 7 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.85e-07 | 196 | 117 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.85e-07 | 196 | 117 | 7 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 9.16e-07 | 197 | 117 | 7 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.47e-07 | 198 | 117 | 7 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.47e-07 | 198 | 117 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.47e-07 | 198 | 117 | 7 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.47e-07 | 198 | 117 | 7 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.80e-07 | 199 | 117 | 7 | d9d7f36b4b5592b7855448730044c90997b55499 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.80e-07 | 199 | 117 | 7 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-06 | 200 | 117 | 7 | a637281d91e95734ee4f8510b3780e0272b16fda | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.01e-06 | 200 | 117 | 7 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.01e-06 | 200 | 117 | 7 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.01e-06 | 200 | 117 | 7 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-06 | 200 | 117 | 7 | 3a164e3971bcd62b148b813171c103adb81f972e | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.01e-06 | 200 | 117 | 7 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.01e-06 | 200 | 117 | 7 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.01e-06 | 200 | 117 | 7 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | COVID-19-lung-Mesothelial|lung / Disease (COVID-19 only), tissue and cell type | 3.59e-06 | 156 | 117 | 6 | e1f563869b3bf997eaa2e756e31b53db1a478903 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 4.47e-06 | 162 | 117 | 6 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 5.50e-06 | 168 | 117 | 6 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 5.89e-06 | 170 | 117 | 6 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBCC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.73e-06 | 174 | 117 | 6 | 912a9e892b29d945666fc37c986009c97c668ac8 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.42e-06 | 177 | 117 | 6 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.66e-06 | 178 | 117 | 6 | 6178706db4a855d72abc156537604d575624df56 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.66e-06 | 178 | 117 | 6 | f02076ece0fa899e620971c887ad4da7f48684ed | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.91e-06 | 179 | 117 | 6 | 056df2aaff750e0e283e7da78fcc3c90c366aac0 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.91e-06 | 179 | 117 | 6 | f5f3945ef3b9efc5921a71fd51deeb2c80f0ce11 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.17e-06 | 180 | 117 | 6 | da723df348d7b8449bb1124f23fe6fa706412adb | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.17e-06 | 180 | 117 | 6 | d9c9399df3e2d9f23dbbfffb6cbe8404bf01e2b7 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.17e-06 | 180 | 117 | 6 | dad458398683ff80a6e207bdc08e257d1bb757d6 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.17e-06 | 180 | 117 | 6 | 5b146a94708b3c3610542a4d0925f3f7a2b19185 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.17e-06 | 180 | 117 | 6 | 50758b1e7be2e43f83c10ab106900c067e61f5f7 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-06 | 181 | 117 | 6 | 0b1e7335648823b1d83bdfa878ccd44efe7bba9a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.43e-06 | 181 | 117 | 6 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.70e-06 | 182 | 117 | 6 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.97e-06 | 183 | 117 | 6 | 8330c39184ce076e1f95fd3725b68af551d89db0 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 9.26e-06 | 184 | 117 | 6 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 9.26e-06 | 184 | 117 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.55e-06 | 185 | 117 | 6 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 9.55e-06 | 185 | 117 | 6 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.55e-06 | 185 | 117 | 6 | d5f5866924648a3c14e2596218fd548a31777aa3 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.84e-06 | 186 | 117 | 6 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.84e-06 | 186 | 117 | 6 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.84e-06 | 186 | 117 | 6 | 74eb69a52090f9e2426a47e03a1c478ee0cfec18 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.05e-05 | 188 | 117 | 6 | 0e2d1b21f0a7ee306e7dae16fc8c19d16a467883 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.08e-05 | 189 | 117 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.08e-05 | 189 | 117 | 6 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.11e-05 | 190 | 117 | 6 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-05 | 190 | 117 | 6 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.11e-05 | 190 | 117 | 6 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-05 | 190 | 117 | 6 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-05 | 190 | 117 | 6 | 7f6dafd5418764d67f6d5ec2153233b791910e81 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-05 | 191 | 117 | 6 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-05 | 191 | 117 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.14e-05 | 191 | 117 | 6 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.14e-05 | 191 | 117 | 6 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 1.14e-05 | 191 | 117 | 6 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 1.14e-05 | 191 | 117 | 6 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.14e-05 | 191 | 117 | 6 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 192 | 117 | 6 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.18e-05 | 192 | 117 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.18e-05 | 192 | 117 | 6 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 192 | 117 | 6 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 1.18e-05 | 192 | 117 | 6 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 193 | 117 | 6 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 193 | 117 | 6 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 193 | 117 | 6 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.21e-05 | 193 | 117 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.21e-05 | 193 | 117 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 193 | 117 | 6 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.25e-05 | 194 | 117 | 6 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| Drug | Kawain [500-64-1]; Down 200; 17.4uM; PC3; HT_HG-U133A | 8.01e-07 | 196 | 117 | 9 | 7369_DN | |
| Drug | geldanamycin | VAPB TET2 BDP1 COL12A1 SETX SPTBN1 RBM26 FRYL BCOR RFX7 NKTR | 3.44e-06 | 371 | 117 | 11 | ctd:C001277 |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 7.15e-06 | 193 | 117 | 8 | 4712_UP | |
| Drug | Zardaverine [101975-10-4]; Down 200; 15uM; PC3; HT_HG-U133A | 8.94e-06 | 199 | 117 | 8 | 4209_DN | |
| Disease | Neurodevelopmental Disorders | 2.99e-05 | 93 | 113 | 5 | C1535926 | |
| Disease | insomnia measurement | 5.38e-05 | 443 | 113 | 9 | EFO_0007876 | |
| Disease | cortical surface area measurement | TET2 FILIP1 DCHS2 ZAN ANK3 SPTBN1 RGPD1 FRYL ADGRV1 MAST4 VCAN MDC1 ADGRL2 FGD6 ARHGAP21 CCDC33 | 5.44e-05 | 1345 | 113 | 16 | EFO_0010736 |
| Disease | alcohol consumption measurement | DLGAP2 COL12A1 PCLO SPTBN1 MFSD6 LRRC4C ADGRV1 MAST4 AKAP11 RPRD2 ADGRL2 MGA EMCN CCDC33 CCSER1 | 8.03e-05 | 1242 | 113 | 15 | EFO_0007878 |
| Disease | Ullrich congenital muscular dystrophy | 8.68e-05 | 4 | 113 | 2 | cv:C4551860 | |
| Disease | Bethlem myopathy | 8.68e-05 | 4 | 113 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 8.68e-05 | 4 | 113 | 2 | C1834674 | |
| Disease | Ullrich congenital muscular dystrophy 1 | 8.68e-05 | 4 | 113 | 2 | C0410179 | |
| Disease | Bethlem myopathy (is_implicated_in) | 8.68e-05 | 4 | 113 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 8.68e-05 | 4 | 113 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.09e-04 | 64 | 113 | 4 | DOID:4947 (is_marker_for) | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.46e-04 | 69 | 113 | 4 | DOID:1682 (implicated_via_orthology) | |
| Disease | coronary artery disease | TET2 COL6A3 FAT4 DSCAM CETP IGSF10 MAST4 PIP4K2B RPRD2 ADGRL2 MUC22 FGD6 SAP130 ARHGAP21 | 1.92e-04 | 1194 | 113 | 14 | EFO_0001645 |
| Disease | cholesteryl ester transfer protein measurement | 2.16e-04 | 6 | 113 | 2 | EFO_0009133 | |
| Disease | brain measurement, neuroimaging measurement | 2.73e-04 | 550 | 113 | 9 | EFO_0004346, EFO_0004464 | |
| Disease | chronic kidney disease | 2.97e-04 | 235 | 113 | 6 | EFO_0003884 | |
| Disease | unipolar depression, bipolar disorder | 3.43e-04 | 156 | 113 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | glycosyl-N-(2-hydroxynervonoyl)-sphingosine (d18:1/24:1(2OH)) measurement | 4.01e-04 | 8 | 113 | 2 | EFO_0800533 | |
| Disease | Adenoid Cystic Carcinoma | 6.03e-04 | 100 | 113 | 4 | C0010606 | |
| Disease | diet measurement | DLGAP2 ANK3 DSCAM MFSD6 RBM26 NLGN1 LRRC4C TEX15 MLLT10 MUC17 ADGRL2 EMCN | 7.00e-04 | 1049 | 113 | 12 | EFO_0008111 |
| Disease | nucleus accumbens volume change measurement | 7.82e-04 | 11 | 113 | 2 | EFO_0021493 | |
| Disease | optic disc size measurement | 1.18e-03 | 205 | 113 | 5 | EFO_0004832 | |
| Disease | wet macular degeneration | 1.28e-03 | 14 | 113 | 2 | EFO_0004683 | |
| Disease | cholesterol to total lipids in large LDL percentage | 1.31e-03 | 56 | 113 | 3 | EFO_0022235 | |
| Disease | melanoma | 1.43e-03 | 126 | 113 | 4 | EFO_0000756 | |
| Disease | low density lipoprotein particle size measurement | 1.45e-03 | 58 | 113 | 3 | EFO_0008593 | |
| Disease | Down syndrome (implicated_via_orthology) | 1.48e-03 | 15 | 113 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | triglycerides to total lipids in chylomicrons and extremely large VLDL percentage | 1.48e-03 | 15 | 113 | 2 | EFO_0022328 | |
| Disease | Hypertriglyceridemia | 1.48e-03 | 15 | 113 | 2 | C0020557 | |
| Disease | bone mineral content measurement | 1.60e-03 | 130 | 113 | 4 | EFO_0007621 | |
| Disease | infant expressive language ability | 1.68e-03 | 16 | 113 | 2 | EFO_0006316 | |
| Disease | lysophosphatidylcholine measurement | 1.75e-03 | 62 | 113 | 3 | EFO_0010224 | |
| Disease | response to radiation, Urinary retention | 1.90e-03 | 17 | 113 | 2 | GO_0009314, HP_0000016 | |
| Disease | Amyotrophic lateral sclerosis | 1.90e-03 | 17 | 113 | 2 | cv:C0002736 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 1.90e-03 | 17 | 113 | 2 | EFO_0022232 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.90e-03 | 17 | 113 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | esterified cholesterol measurement, high density lipoprotein cholesterol measurement | 2.38e-03 | 19 | 113 | 2 | EFO_0004612, EFO_0008589 | |
| Disease | nephrotic syndrome | 2.59e-03 | 71 | 113 | 3 | EFO_0004255 | |
| Disease | lung carcinoma | 2.60e-03 | 482 | 113 | 7 | EFO_0001071 | |
| Disease | Osteoarthritis of hip | 2.64e-03 | 20 | 113 | 2 | C0029410 | |
| Disease | neuroimaging measurement | DCHS2 CDC42BPA ANK3 SPTBN1 RBM26 RGPD1 FRYL MLLT10 MAST4 VCAN FGD6 | 2.69e-03 | 1069 | 113 | 11 | EFO_0004346 |
| Disease | osteoporosis | 2.80e-03 | 73 | 113 | 3 | EFO_0003882 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.82e-03 | 152 | 113 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | treatment resistant depression, response to antidepressant | 2.91e-03 | 21 | 113 | 2 | EFO_0009854, GO_0036276 | |
| Disease | skin hydration measurement | 2.91e-03 | 21 | 113 | 2 | EFO_0009586 | |
| Disease | free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 2.91e-03 | 21 | 113 | 2 | EFO_0022277 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 2.91e-03 | 21 | 113 | 2 | EFO_0022246 | |
| Disease | Nystagmus | 2.91e-03 | 21 | 113 | 2 | HP_0000639 | |
| Disease | asthma, response to diisocyanate | 3.37e-03 | 261 | 113 | 5 | EFO_0006995, MONDO_0004979 | |
| Disease | Autistic Disorder | 3.37e-03 | 261 | 113 | 5 | C0004352 | |
| Disease | gut microbiome measurement, bone density | 3.38e-03 | 78 | 113 | 3 | EFO_0003923, EFO_0007874 | |
| Disease | frailty measurement | 3.49e-03 | 23 | 113 | 2 | EFO_0009885 | |
| Disease | response to clopidogrel, cardiovascular event measurement | 3.49e-03 | 23 | 113 | 2 | EFO_0006919, GO_1903493 | |
| Disease | Nonsyndromic Deafness | 3.76e-03 | 81 | 113 | 3 | C3711374 | |
| Disease | pyruvate measurement | 3.77e-03 | 268 | 113 | 5 | EFO_0010117 | |
| Disease | Sjogren's syndrome (is_marker_for) | 3.80e-03 | 24 | 113 | 2 | DOID:12894 (is_marker_for) | |
| Disease | Dyslipidemias | 3.80e-03 | 24 | 113 | 2 | C0242339 | |
| Disease | Dyslipoproteinemias | 3.80e-03 | 24 | 113 | 2 | C0598784 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SLSSITSVTVKIDGV | 346 | Q0P6H9 | |
| TEITSKVEKSPTTAT | 171 | Q9H6B1 | |
| TTTTTSVKKEELVPS | 571 | O75150 | |
| TSSLVKSSVSVPSES | 101 | A6H8Y1 | |
| ITPKTVSNLTESSSE | 406 | P11597 | |
| FSTIKVTVPSDITTA | 1196 | P13611 | |
| SSKAVTSVTSEPTRA | 276 | Q8N5R6 | |
| VPVFSKAETSTLTIS | 241 | Q8N157 | |
| TPVSIQLVTSTSVLS | 1241 | Q8IZF6 | |
| STPRTDTSTVSIVLL | 2236 | Q6V0I7 | |
| PSRKTITITVKSVTS | 406 | Q9NZU0 | |
| LSTSKTTTILQPTNV | 5161 | Q8WXG9 | |
| PTTAVTITSSAELFK | 401 | O95490 | |
| LPSVKTSVTTSISEP | 261 | Q9UKA4 | |
| TTTTTIATVTTEDRK | 626 | O14490 | |
| TSKPLISVTAQSSTE | 621 | Q9P1A6 | |
| AAVTKTTTELTGTVP | 301 | Q9C0I3 | |
| LQPTSSISTTKTTLG | 1631 | Q9P1Z9 | |
| TKTSRSSVETTPSVI | 581 | Q6W2J9 | |
| STTPESITEKSSIAT | 1061 | Q8WWL7 | |
| ILTKPTTTATTTAST | 1906 | Q9HC84 | |
| PKVLTTTATTPTVTS | 1936 | Q9HC84 | |
| TKVLTTTTTGFTATP | 2606 | Q9HC84 | |
| RTATTLPVLTSTATK | 3046 | Q9HC84 | |
| LPVLTSTATKSTATS | 3051 | Q9HC84 | |
| GTLKVLTSTATTPTV | 3191 | Q9HC84 | |
| HTTKVPTTTTTGFTV | 3861 | Q9HC84 | |
| TTLPVLTSTATKSTA | 4306 | Q9HC84 | |
| TPETTHTSTVLTTKA | 4356 | Q9HC84 | |
| TATTLPVLTSTATKS | 4731 | Q9HC84 | |
| EVSSTSETTPKAVVS | 2496 | P49792 | |
| VSKPSVSATEKVLST | 676 | Q5T8P6 | |
| VSSTSETTTKAVVSP | 1521 | Q99666 | |
| VSSTSETTTKAVVSP | 1521 | O14715 | |
| TATVISKTIITTNPD | 246 | Q8N635 | |
| KEDVTVSPSSKTITS | 851 | P0C881 | |
| KEDVTVSPSSKTITS | 851 | B2RC85 | |
| TSADGKPTTIITTTQ | 726 | P51610 | |
| TISSLGTPSISTKQT | 346 | Q8WXI7 | |
| SVPSVVSGFTTLKTS | 561 | Q8WXI7 | |
| SSISVPAKTSLVETT | 3146 | Q8WXI7 | |
| AVKTETSTSERTLSP | 3651 | Q8WXI7 | |
| KLTSPVVTTSTREQA | 3976 | Q8WXI7 | |
| QTSIISSPGSTAITK | 4031 | Q8WXI7 | |
| IPKSSKTTRTETETT | 4876 | Q8WXI7 | |
| KTTRTETETTSSLTP | 4881 | Q8WXI7 | |
| LSKVPTGTITEVSST | 5211 | Q8WXI7 | |
| TALPTSVLVTTTDVL | 5366 | Q8WXI7 | |
| ISPEISTETITRIST | 8761 | Q8WXI7 | |
| EPSKVTSPVVTSSTI | 8961 | Q8WXI7 | |
| TSPVVTSSTIKDIVS | 8966 | Q8WXI7 | |
| TSSTIKDIVSTTIPA | 8971 | Q8WXI7 | |
| KDIVSTTIPASSEIT | 8976 | Q8WXI7 | |
| VITRLSTSPIKTEST | 9061 | Q8WXI7 | |
| SATEKSTVLSSVPTG | 9301 | Q8WXI7 | |
| EPTKVISPVVTSSSI | 9541 | Q8WXI7 | |
| LVTSSRAVTSTTIPI | 11101 | Q8WXI7 | |
| LVVTTTKPSITTPNT | 31 | Q9ULC0 | |
| TLRSTATKPTVTQAT | 1291 | Q6W4X9 | |
| VITIVKSTELSSTSV | 136 | O60675 | |
| VKKSRTTSSSVIVPE | 181 | Q14676 | |
| VRKDTLQTVSSSPVT | 391 | Q5T3J3 | |
| VVSSAKSSSPDTVTI | 451 | Q9Y692 | |
| ITLPVASTASTSLVV | 1686 | Q8IWI9 | |
| ETTTILIKASETTTA | 276 | E2RYF6 | |
| TVSSTTFVLTKATDV | 1531 | E2RYF6 | |
| VDTPVSTLTPVKTSE | 116 | Q96L50 | |
| SSVSSVNPSVTTIKT | 156 | Q8TBA6 | |
| SISSSVKATSPVKST | 286 | Q9NQW6 | |
| VKATSPVKSTTSITD | 291 | Q9NQW6 | |
| TTEVSPTSQKTTTKT | 306 | P08174 | |
| LKTAPVTTTSAVSKS | 661 | Q9Y6V0 | |
| KPTTDLVSSSSATTK | 761 | Q9Y6V0 | |
| TIKPSGTTISVTASV | 336 | P55058 | |
| TLTDLTNPTITVVTS | 361 | Q9NQ69 | |
| PTTVTASTGVKETSE | 8096 | Q7Z5P9 | |
| FTTLKTAVTSTSPIT | 246 | Q02505 | |
| KTPTTNLVTTTTKTT | 756 | Q02505 | |
| VTTLPITITRSTLTS | 1446 | Q02505 | |
| ETAKTPTTNLVTTTT | 1506 | Q02505 | |
| TVPTTNLVTTTTKIT | 1886 | Q02505 | |
| VTTTKTTSHITPGLT | 2396 | Q02505 | |
| KPKVIAVTRSTSSTS | 2321 | O94915 | |
| KDKTSTVAPTIHTTV | 191 | P13473 | |
| TSEATFQTTLPTLKV | 596 | Q6W3E5 | |
| PLTVTAALTSITASV | 771 | Q6ZVL6 | |
| QSTRSTEKTFTIPVT | 496 | Q9HCJ2 | |
| LTTAVISATPAVLTT | 871 | Q9NQV6 | |
| QYTSTTTKVPSTDIT | 661 | Q8N2Q7 | |
| ITKTESLVIPSTRSE | 411 | Q86VP3 | |
| SPGSVTKETTTVIVT | 251 | Q6ZSS7 | |
| TPALSSSQTLTVTVL | 1701 | Q6V1P9 | |
| SSTKSIISTQTAIPA | 1306 | Q6WRI0 | |
| AITVFILSTSPEVTT | 1831 | Q86XA9 | |
| SRSPSKVEVTEKTTT | 466 | O14523 | |
| ASSTSVVLSSLKPET | 681 | Q99715 | |
| KVTSSITITPTATPL | 1106 | Q4L180 | |
| QPRLTVSKTSASSIT | 1386 | Q8TD84 | |
| EIEPSSSTTTASVTK | 1346 | Q8N3K9 | |
| VTTTKPVTTTKPVTT | 2871 | P12111 | |
| ISSSDATVKILITTV | 166 | Q12905 | |
| PVKVRSTCVTTTTTT | 3951 | Q12955 | |
| VSITTTPFENTSIKT | 1221 | O15021 | |
| SSVVTVPSSSLGTKT | 66 | P01861 | |
| AVKPSISETVSVTSH | 1371 | Q8NDH2 | |
| PITTKTDKTSTTGSI | 501 | Q9ULU4 | |
| VLASTISTTSTIEFK | 996 | Q5VT52 | |
| TILSVTPHTTTSVLI | 1506 | Q58EX2 | |
| VSSTSETTTKAVVSP | 1506 | P0DJD0 | |
| STTSTIPVDSKTFVT | 411 | Q685J3 | |
| NTLSTTPIDSKTQVT | 1591 | Q685J3 | |
| ISTLGTTILVSTTPV | 3751 | Q685J3 | |
| VFTTLKTAVTSTSPI | 246 | Q9H195 | |
| KTAVTSTSPITSTIT | 251 | Q9H195 | |
| STLVTTLPTAIARST | 316 | Q9H195 | |
| DQPRLTVSKTTSSSI | 1381 | O60469 | |
| PLVTSVANTVTTVSL | 436 | Q92750 | |
| VTVGSLKTSAVPSTS | 341 | Q86WV6 | |
| TTSVSKALSDTTVVT | 716 | O60522 | |
| EVISSSTKNSPSTRV | 141 | Q5JRV8 | |
| GASKVTSTITITPVT | 1121 | Q7Z7B0 | |
| ATSSAVEVKVLTTVP | 1241 | P30414 | |
| LTNITVTPITTAAAT | 1366 | P57071 | |
| TFTTVIPATLTIRST | 226 | Q7Z3K3 | |
| TSTTAVAVAPLSASK | 6 | P78356 | |
| APALQTVITTTTKVS | 376 | O75603 | |
| IKPVIVTDSSVTTSL | 466 | Q96QT6 | |
| TPSDSKEITLTVTSK | 2511 | Q7Z333 | |
| DLTASEVSKIVTVST | 366 | Q562F6 | |
| LTTLTPVSESSKVVV | 616 | P48029 | |
| LSTVPSVTKTQASSS | 661 | P46087 | |
| TVFSGSVSIPSITKS | 1606 | Q5VT25 | |
| QDTTPFKITTLKTTT | 966 | Q92954 | |
| TSVVTITSESSPGKR | 2331 | Q01082 | |
| VPSLTVTTEKTYTST | 256 | P55197 | |
| TVILTVSTSLSPRSE | 261 | Q9H3R2 | |
| SSSKVTTVLRPTSQL | 241 | Q9H0E3 | |
| VTVSSNSEPSTALTK | 586 | Q6ZV73 | |
| EVKTRASTVSSVVST | 466 | Q9UBT6 | |
| RTKTISATATTEALP | 1516 | P24821 | |
| SVTLTPTPVKSTADI | 1866 | O60281 | |
| TTVLFTSSPIKTAVV | 351 | Q2KHR2 | |
| ILTTTATLPAVVTVT | 271 | Q9UHR5 | |
| LEVSTETKVTSTVPL | 226 | O43379 | |
| SITSKPATLTTTSAT | 346 | O43670 | |
| KAISSPTVSRLTDTT | 156 | O94811 | |
| SSVSPPQIISSTIKT | 221 | Q09FC8 | |
| ISTTASKTETPIVSK | 141 | O95292 | |
| SKTETPIVSKSLSSS | 146 | O95292 | |
| SVVSSITIPAVVSIS | 1411 | Q9H4A3 | |
| VSLETSLVIESTVTP | 1676 | Q9H4A3 | |
| ITQELEITKSSTSTI | 301 | Q9BXT5 | |
| SEQTSLKTVSRTTSP | 306 | Q5T5U3 | |
| TSSEKTPTKRTAASV | 1086 | Q6N021 | |
| SAVISTTTIATTPSK | 211 | P08575 | |
| KPATKTAELSVVSTS | 206 | P18583 | |
| PTTTLVLKSSEPVVT | 251 | P18583 | |
| LESSTVTVLEPSVVT | 1376 | P18583 | |
| RKSLSPVTVSQTSVV | 646 | Q5JNZ3 | |
| TSVEETTISTEKLTI | 831 | Q9Y493 | |
| TEETTISTEKLTIPT | 931 | Q9Y493 | |
| SSVASDVSKPVLTTK | 51 | Q9BT73 |